A biodegradable injectable device for protection of the rectal wall when treating prostate cancer with radiation. Barrigel is approved for prostate rectum separation in Australia, Europe and the United States, and will be further developed for future market introduction in Japan.

—

Q-Med is the current legal manufacturer and holds the CE Mark.